300 Shares in Danaher Co. (NYSE:DHR) Purchased by Crowley Wealth Management Inc.

Crowley Wealth Management Inc. purchased a new stake in Danaher Co. (NYSE:DHR) during the 4th quarter, Holdings Channel reports. The fund purchased 300 shares of the conglomerate’s stock, valued at approximately $69,000.

Several other institutional investors and hedge funds also recently modified their holdings of DHR. Heck Capital Advisors LLC purchased a new stake in Danaher in the 4th quarter valued at approximately $27,000. Decker Retirement Planning Inc. purchased a new stake in shares of Danaher in the fourth quarter valued at $31,000. Golden State Wealth Management LLC purchased a new stake in shares of Danaher in the fourth quarter valued at $31,000. Strategic Financial Concepts LLC purchased a new position in Danaher in the 4th quarter valued at about $31,000. Finally, Pineridge Advisors LLC lifted its holdings in Danaher by 63.3% in the 4th quarter. Pineridge Advisors LLC now owns 147 shares of the conglomerate’s stock valued at $34,000 after purchasing an additional 57 shares in the last quarter. Hedge funds and other institutional investors own 79.05% of the company’s stock.

Danaher Stock Performance

Shares of NYSE:DHR opened at $211.63 on Monday. The company has a market cap of $151.26 billion, a P/E ratio of 40.08, a PEG ratio of 2.66 and a beta of 0.82. The company has a debt-to-equity ratio of 0.31, a quick ratio of 1.05 and a current ratio of 1.40. Danaher Co. has a one year low of $196.80 and a one year high of $281.70. The business’s 50-day simple moving average is $217.46 and its 200 day simple moving average is $238.50.

Danaher (NYSE:DHR) last posted its quarterly earnings data on Wednesday, January 29th. The conglomerate reported $2.14 earnings per share (EPS) for the quarter, meeting analysts’ consensus estimates of $2.14. Danaher had a net margin of 16.33% and a return on equity of 10.82%. During the same quarter last year, the company earned $2.09 EPS. On average, sell-side analysts forecast that Danaher Co. will post 7.63 earnings per share for the current fiscal year.

Danaher Increases Dividend

The company also recently declared a quarterly dividend, which will be paid on Friday, April 25th. Investors of record on Friday, March 28th will be paid a dividend of $0.32 per share. This is an increase from Danaher’s previous quarterly dividend of $0.27. The ex-dividend date of this dividend is Friday, March 28th. This represents a $1.28 annualized dividend and a yield of 0.60%. Danaher’s payout ratio is 24.24%.

Wall Street Analyst Weigh In

DHR has been the topic of several recent analyst reports. JPMorgan Chase & Co. reduced their price objective on shares of Danaher from $310.00 to $300.00 and set an “overweight” rating on the stock in a research note on Tuesday, January 28th. Wells Fargo & Company reduced their price target on Danaher from $280.00 to $240.00 and set an “equal weight” rating on the stock in a research note on Thursday, January 30th. Guggenheim initiated coverage on Danaher in a research note on Thursday, December 19th. They set a “buy” rating and a $275.00 price target on the stock. Stifel Nicolaus upgraded Danaher from a “hold” rating to a “buy” rating and set a $260.00 target price on the stock in a research report on Friday, March 14th. Finally, StockNews.com downgraded Danaher from a “buy” rating to a “hold” rating in a research report on Saturday, December 14th. Five equities research analysts have rated the stock with a hold rating and seventeen have given a buy rating to the company’s stock. According to data from MarketBeat, Danaher has a consensus rating of “Moderate Buy” and an average price target of $278.24.

Insider Transactions at Danaher

In other Danaher news, SVP Brian W. Ellis sold 5,700 shares of Danaher stock in a transaction that occurred on Thursday, January 30th. The stock was sold at an average price of $224.13, for a total transaction of $1,277,541.00. Following the sale, the senior vice president now directly owns 20,230 shares in the company, valued at $4,534,149.90. The trade was a 21.98 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Corporate insiders own 11.10% of the company’s stock.

About Danaher

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.